Skip to main content
PMC home page
Gut logoLink to Gut
. 1980 Apr;21(4):329–333. doi: 10.1136/gut.21.4.329

Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.

G Vantrappen, P Rutgeerts, L Broeckaert, J Janssens
PMCID: PMC1419618  PMID: 7000628

Abstract

In a study of 28 outpatients with endoscopically proven duodenal ulcers, 14 patients (with a total of 15 ulcers) were treated with bismuth tablets (colloidal bismuth subcitrate, De-Nol, Gist-Brocades NV) and 14 patients (14 ulcers) were treated with cimetidine (Smith, Kline, and French). Clinical and endoscopic assessments were made after four and six weeks' therapy. After four weeks, 10 of the bismuth treated ulcers (67%) and eight of the cimetidine treated ulcers (57%) were completely healed. After six weeks of therapy, complete healing was seen in 86% of both the bismuth treated and the cimetidine treated ulcers. Twenty of the 24 completely healed ulcer patients (10 of each group) cooperated in a three month follow-up study. Pain recurred in three patients of the bismuth group and four of the cimetidine group and they were examined endoscopically. A recurrent ulcer was found in one of the bismuth treated patients and in three of the cimetidine treated patients. These observations indicate that colloidal bismuth subcitrate was at least as effective as cimetidine in the healing of duodenal ulcer.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binder H. J., Cocco A., Crossley R. J., Finkelstein W., Font R., Friedman G., Groarke J., Hughes W., Johnson A. F., McGuigan J. E. Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology. 1978 Feb;74(2 Pt 2):380–388. [PubMed] [Google Scholar]
  2. Blackwood W. S., Maudgal D. P., Pickard R. G., Lawrence D., Northfield T. C. Cimetidine in duodenal ulcer. Controlled trial. Lancet. 1976 Jul 24;2(7978):174–176. doi: 10.1016/s0140-6736(76)92347-3. [DOI] [PubMed] [Google Scholar]
  3. Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer. Drugs. 1976 Dec;12(6):401–411. doi: 10.2165/00003495-197612060-00001. [DOI] [PubMed] [Google Scholar]
  4. Burns R., Thomas D. W., Barron V. J. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J. 1974 Feb 9;1(5901):220–223. doi: 10.1136/bmj.1.5901.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delle Fave G. F., Tamburrano G., De Magistris L., Natoli C., Santoro M. L., Carratu R., Torsoli A. Gynaecomastia with cimetidine. Lancet. 1977 Jun 18;1(8025):1319–1319. doi: 10.1016/s0140-6736(77)91358-7. [DOI] [PubMed] [Google Scholar]
  6. Englert E., Jr, Freston J. W., Graham D. Y., Finkelstein W., Kruss D. M., Priest R. J., Raskin J. B., Rhodes J. B., Rogers A. I., Wenger J. Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology. 1978 Feb;74(2 Pt 2):416–425. [PubMed] [Google Scholar]
  7. Grandjean E. M., Ducommun E., Gauthier G., Courvoisier B. L'encéphalopathie myoclonique associée aux sels de bismuth recherche négative d'un élément toxique associé. Schweiz Med Wochenschr. 1976 Jul 24;106(30):1006–1011. [PubMed] [Google Scholar]
  8. Hall W. H. Letter: Breast changes in males on cimetidine. N Engl J Med. 1976 Oct 7;295(15):841–841. doi: 10.1056/NEJM197610072951514. [DOI] [PubMed] [Google Scholar]
  9. Hetzel D. J., Taggart G. J., Hansky J., Hecker R., Shearman D. J. Cimetidine in the treatment of duodenal ulcer. Med J Aust. 1977 Mar 5;1(10):317–319. [PubMed] [Google Scholar]
  10. Hillemand P., Pallière M., Laquais B., Bouvet P. Traitement bismuthique et bismuthémie. Sem Hop. 1977 Sep;53(31-32):1663–1669. [PubMed] [Google Scholar]
  11. Loiseau P., Henry P., Jallon P., Legroux M. Encéphalopathies myocloniques iatrogènes aux sels de bismuth. J Neurol Sci. 1976 Feb;27(2):133–143. doi: 10.1016/0022-510x(76)90056-3. [DOI] [PubMed] [Google Scholar]
  12. Morgan F. P., Billings J. J. Is this subgallate poisoning? Med J Aust. 1974 Nov 2;2(18):662–663. doi: 10.5694/j.1326-5377.1974.tb71075.x. [DOI] [PubMed] [Google Scholar]
  13. Robinson T. J., Mulligan T. O. Cimetidine and mental-confusion. Lancet. 1977 Oct 1;2(8040):719–719. doi: 10.1016/s0140-6736(77)90530-x. [DOI] [PubMed] [Google Scholar]
  14. Salmon P. R., Brown P., Williams R., Read A. E. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Gut. 1974 Mar;15(3):189–193. doi: 10.1136/gut.15.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wallace W. A., Orr C. M., Bearn A. R. Perforation of chronic peptic ulcers after cimetidine. Br Med J. 1977 Oct 1;2(6091):865–866. doi: 10.1136/bmj.2.6091.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Witzel L., Halter F., Olah A. J., Häcki W. H. Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology. 1977 Oct;73(4 Pt 1):797–803. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES